Hardware, Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
MPTI vs VECO vs UCTT vs ACMR vs ICHR
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
MPTI vs VECO vs UCTT vs ACMR vs ICHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $220M | $3.52B | $3.63B | $3.92B | $2.47B |
| Revenue (TTM) | $54M | $655M | $2.07B | $901M | $959M |
| Net Income (TTM) | $8M | $23M | $-194M | $94M | $-51M |
| Gross Margin | 44.4% | 38.6% | 15.6% | 44.4% | 11.3% |
| Operating Margin | 18.9% | 2.9% | -5.3% | 12.1% | -3.8% |
| Forward P/E | 31.1x | 34.5x | 34.4x | 29.7x | 62.2x |
| Total Debt | $148K | $258M | $810M | $303M | $186M |
| Cash & Equiv. | $21M | $163M | $312M | $766M | $98M |
MPTI vs VECO vs UCTT vs ACMR vs ICHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 22 | May 26 | Return |
|---|---|---|---|
| M-tron Industries, … (MPTI) | 100 | 744.3 | +644.3% |
| Veeco Instruments I… (VECO) | 100 | 316.6 | +216.6% |
| Ultra Clean Holding… (UCTT) | 100 | 256.8 | +156.8% |
| ACM Research, Inc. (ACMR) | 100 | 925.0 | +825.0% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 280.0 | +180.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MPTI vs VECO vs UCTT vs ACMR vs ICHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MPTI carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 1.44, Low D/E 0.2%, current ratio 12.52x
- PEG 0.71 vs ACMR's 0.84
- Beta 1.44, current ratio 12.52x
- Lower P/E (31.1x vs 62.2x)
VECO lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, UCTT doesn't own a clear edge in any measured category.
ACMR is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 3 yrs, beta 3.24, yield 0.2%
- Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
- 30.7% 10Y total return vs MPTI's 485.2%
- 15.2% revenue growth vs VECO's -7.4%
ICHR ranks third and is worth considering specifically for momentum.
- +329.1% vs MPTI's +36.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% revenue growth vs VECO's -7.4% | |
| Value | Lower P/E (31.1x vs 62.2x) | |
| Quality / Margins | 15.5% margin vs UCTT's -9.4% | |
| Stability / Safety | Beta 1.44 vs ICHR's 3.93, lower leverage | |
| Dividends | 0.2% yield; 3-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +329.1% vs MPTI's +36.8% | |
| Efficiency (ROA) | 18.0% ROA vs UCTT's -11.0%, ROIC 25.3% vs 2.6% |
MPTI vs VECO vs UCTT vs ACMR vs ICHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
MPTI vs VECO vs UCTT vs ACMR vs ICHR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MPTI leads in 4 of 6 categories
ACMR leads 1 • VECO leads 0 • UCTT leads 0 • ICHR leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MPTI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UCTT is the larger business by revenue, generating $2.1B annually — 38.0x MPTI's $54M. MPTI is the more profitable business, keeping 15.5% of every revenue dollar as net income compared to UCTT's -9.4%. On growth, MPTI holds the edge at +11.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $54M | $655M | $2.1B | $901M | $959M |
| EBITDAEarnings before interest/tax | $11M | $39M | -$52M | $126M | -$11M |
| Net IncomeAfter-tax profit | $8M | $23M | -$194M | $94M | -$51M |
| Free Cash FlowCash after capex | $8M | $43M | -$44M | -$69M | -$17M |
| Gross MarginGross profit ÷ Revenue | +44.4% | +38.6% | +15.6% | +44.4% | +11.3% |
| Operating MarginEBIT ÷ Revenue | +18.9% | +2.9% | -5.3% | +12.1% | -3.8% |
| Net MarginNet income ÷ Revenue | +15.5% | +3.5% | -9.4% | +10.4% | -5.3% |
| FCF MarginFCF ÷ Revenue | +14.9% | +6.5% | -2.1% | -7.6% | -1.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.2% | -5.4% | +2.9% | +9.4% | +4.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +35.6% | -105.0% | -2.6% | -76.1% | +46.2% |
Valuation Metrics
MPTI leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 29.3x trailing earnings, MPTI trades at a 70% valuation discount to VECO's 97.8x P/E. Adjusting for growth (PEG ratio), MPTI offers better value at 0.67x vs ACMR's 1.22x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $220M | $3.5B | $3.6B | $3.9B | $2.5B |
| Enterprise ValueMkt cap + debt − cash | $200M | $3.6B | $4.1B | $3.5B | $2.6B |
| Trailing P/EPrice ÷ TTM EPS | 29.26x | 97.83x | -19.98x | 43.21x | -46.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.07x | 34.52x | 34.44x | 29.68x | 62.25x |
| PEG RatioP/E ÷ EPS growth rate | 0.67x | — | — | 1.22x | — |
| EV / EBITDAEnterprise value multiple | 17.54x | 93.12x | 34.53x | 27.49x | — |
| Price / SalesMarket cap ÷ Revenue | 4.05x | 5.30x | 1.77x | 4.35x | 2.61x |
| Price / BookPrice ÷ Book value/share | 3.91x | 3.95x | 4.62x | 2.06x | 3.67x |
| Price / FCFMarket cap ÷ FCF | 27.17x | 77.08x | 247.26x | — | — |
Profitability & Efficiency
MPTI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MPTI delivers a 20.1% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-25 for UCTT. MPTI carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to UCTT's 1.03x. On the Piotroski fundamental quality scale (0–9), VECO scores 6/9 vs ACMR's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.1% | +2.6% | -25.4% | +6.1% | -7.5% |
| ROA (TTM)Return on assets | +18.0% | +1.8% | -11.0% | +3.9% | -5.2% |
| ROICReturn on invested capital | +25.3% | +2.8% | +2.6% | +7.0% | -3.9% |
| ROCEReturn on capital employed | +21.7% | +3.2% | +2.9% | +6.6% | -4.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.00x | 0.29x | 1.03x | 0.16x | 0.28x |
| Net DebtTotal debt minus cash | -$21M | $94M | $499M | -$463M | $87M |
| Cash & Equiv.Liquid assets | $21M | $163M | $312M | $766M | $98M |
| Total DebtShort + long-term debt | $148,000 | $258M | $810M | $303M | $186M |
| Interest CoverageEBIT ÷ Interest expense | — | 3.64x | -5.80x | 20.44x | -5.97x |
Total Returns (Dividends Reinvested)
MPTI leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MPTI five years ago would be worth $58,519 today (with dividends reinvested), compared to $12,895 for ICHR. Over the past 12 months, ICHR leads with a +329.1% total return vs MPTI's +36.8%. The 3-year compound annual growth rate (CAGR) favors MPTI at 86.2% vs ICHR's 35.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +47.2% | +89.0% | +192.5% | +31.9% | +249.0% |
| 1-Year ReturnPast 12 months | +36.8% | +205.6% | +312.7% | +195.6% | +329.1% |
| 3-Year ReturnCumulative with dividends | +545.9% | +199.8% | +187.5% | +487.9% | +151.1% |
| 5-Year ReturnCumulative with dividends | +485.2% | +154.6% | +59.4% | +133.4% | +28.9% |
| 10-Year ReturnCumulative with dividends | +485.2% | +239.9% | +1385.1% | +3065.8% | +629.1% |
| CAGR (3Y)Annualised 3-year return | +86.2% | +44.2% | +42.2% | +80.5% | +35.9% |
Risk & Volatility
Evenly matched — MPTI and ICHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
MPTI is the less volatile stock with a 1.44 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 97.7% from its 52-week high vs ACMR's 82.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.44x | 1.97x | 3.19x | 3.24x | 3.93x |
| 52-Week HighHighest price in past year | $79.58 | $64.97 | $87.68 | $71.65 | $72.87 |
| 52-Week LowLowest price in past year | $36.38 | $18.31 | $18.52 | $19.26 | $13.12 |
| % of 52W HighCurrent price vs 52-week peak | +96.3% | +88.8% | +91.1% | +82.6% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 63.7 | 82.2 | 62.3 | 60.7 | 66.9 |
| Avg Volume (50D)Average daily shares traded | 84K | 1.3M | 1.3M | 1.2M | 795K |
Analyst Outlook
ACMR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: MPTI as "Buy", VECO as "Buy", UCTT as "Buy", ACMR as "Buy", ICHR as "Buy". Consensus price targets imply 6.4% upside for UCTT (target: $85) vs -39.8% for VECO (target: $35). ACMR is the only dividend payer here at 0.19% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $34.75 | $85.00 | $40.00 | $49.80 |
| # AnalystsCovering analysts | 1 | 36 | 12 | 10 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.2% | — |
| Dividend StreakConsecutive years of raises | — | — | 1 | 3 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | $0.11 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.1% | +0.2% | 0.0% |
MPTI leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). ACMR leads in 1 (Analyst Outlook). 1 tied.
MPTI vs VECO vs UCTT vs ACMR vs ICHR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MPTI or VECO or UCTT or ACMR or ICHR a better buy right now?
For growth investors, ACM Research, Inc.
(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -7. 4% for Veeco Instruments Inc. (VECO). M-tron Industries, Inc. (MPTI) offers the better valuation at 29. 3x trailing P/E (31. 1x forward), making it the more compelling value choice. Analysts rate M-tron Industries, Inc. (MPTI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MPTI or VECO or UCTT or ACMR or ICHR?
On trailing P/E, M-tron Industries, Inc.
(MPTI) is the cheapest at 29. 3x versus Veeco Instruments Inc. at 97. 8x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: M-tron Industries, Inc. wins at 0. 71x versus ACM Research, Inc. 's 0. 84x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MPTI or VECO or UCTT or ACMR or ICHR?
Over the past 5 years, M-tron Industries, Inc.
(MPTI) delivered a total return of +485. 2%, compared to +28. 9% for Ichor Holdings, Ltd. (ICHR). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus VECO's +239. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MPTI or VECO or UCTT or ACMR or ICHR?
By beta (market sensitivity over 5 years), M-tron Industries, Inc.
(MPTI) is the lower-risk stock at 1. 44β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 174% more volatile than MPTI relative to the S&P 500. On balance sheet safety, M-tron Industries, Inc. (MPTI) carries a lower debt/equity ratio of 0% versus 103% for Ultra Clean Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MPTI or VECO or UCTT or ACMR or ICHR?
By revenue growth (latest reported year), ACM Research, Inc.
(ACMR) is pulling ahead at 15. 2% versus -7. 4% for Veeco Instruments Inc. (VECO). On earnings-per-share growth, the picture is similar: M-tron Industries, Inc. grew EPS -1. 1% year-over-year, compared to -869. 2% for Ultra Clean Holdings, Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MPTI or VECO or UCTT or ACMR or ICHR?
M-tron Industries, Inc.
(MPTI) is the more profitable company, earning 15. 5% net margin versus -8. 8% for Ultra Clean Holdings, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MPTI leads at 18. 9% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — ACMR leads at 44. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MPTI or VECO or UCTT or ACMR or ICHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, M-tron Industries, Inc. (MPTI) is the more undervalued stock at a PEG of 0. 71x versus ACM Research, Inc. 's 0. 84x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACM Research, Inc. (ACMR) trades at 29. 7x forward P/E versus 62. 2x for Ichor Holdings, Ltd. — 32. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UCTT: 6. 4% to $85. 00.
08Which pays a better dividend — MPTI or VECO or UCTT or ACMR or ICHR?
In this comparison, ACMR (0.
2% yield) pays a dividend. MPTI, VECO, UCTT, ICHR do not pay a meaningful dividend and should not be held primarily for income.
09Is MPTI or VECO or UCTT or ACMR or ICHR better for a retirement portfolio?
For long-horizon retirement investors, Ultra Clean Holdings, Inc.
(UCTT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1385% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UCTT: +1385%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MPTI and VECO and UCTT and ACMR and ICHR?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MPTI is a small-cap quality compounder stock; VECO is a small-cap quality compounder stock; UCTT is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.